These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 26585243

  • 21. Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities.
    Du X, Zuo X, Meng F, Wu F, Zhao X, Li C, Cheng G, Qin FX.
    Biochem Biophys Res Commun; 2020 Feb 19; 522(4):862-868. PubMed ID: 31806372
    [Abstract] [Full Text] [Related]

  • 22. Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses.
    Galindo I, Garaigorta U, Lasala F, Cuesta-Geijo MA, Bueno P, Gil C, Delgado R, Gastaminza P, Alonso C.
    Antiviral Res; 2021 Feb 19; 186():104990. PubMed ID: 33249093
    [Abstract] [Full Text] [Related]

  • 23. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.
    Bennett RP, Finch CL, Postnikova EN, Stewart RA, Cai Y, Yu S, Liang J, Dyall J, Salter JD, Smith HC, Kuhn JH.
    Viruses; 2020 Dec 31; 13(1):. PubMed ID: 33396288
    [Abstract] [Full Text] [Related]

  • 24. Ebola Virus Entry: From Molecular Characterization to Drug Discovery.
    Salata C, Calistri A, Alvisi G, Celestino M, Parolin C, Palù G.
    Viruses; 2019 Mar 19; 11(3):. PubMed ID: 30893774
    [Abstract] [Full Text] [Related]

  • 25. Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry.
    Schafer A, Xiong R, Cooper L, Nowar R, Lee H, Li Y, Ramirez BE, Peet NP, Caffrey M, Thatcher GRJ, Saphire EO, Cheng H, Rong L.
    PLoS Pathog; 2021 Feb 19; 17(2):e1009312. PubMed ID: 33539432
    [Abstract] [Full Text] [Related]

  • 26. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.
    Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA.
    Science; 2015 Feb 27; 347(6225):995-8. PubMed ID: 25722412
    [Abstract] [Full Text] [Related]

  • 27. Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.
    Falzarano D.
    Methods Mol Biol; 2017 Feb 27; 1628():203-210. PubMed ID: 28573622
    [Abstract] [Full Text] [Related]

  • 28. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W, Liu S.
    Curr Top Med Chem; 2017 Feb 27; 17(3):361-370. PubMed ID: 27572081
    [Abstract] [Full Text] [Related]

  • 29. The molecular tweezer CLR01 inhibits Ebola and Zika virus infection.
    Röcker AE, Müller JA, Dietzel E, Harms M, Krüger F, Heid C, Sowislok A, Riber CF, Kupke A, Lippold S, von Einem J, Beer J, Knöll B, Becker S, Schmidt-Chanasit J, Otto M, Vapalahti O, Zelikin AN, Bitan G, Schrader T, Münch J.
    Antiviral Res; 2018 Apr 27; 152():26-35. PubMed ID: 29428508
    [Abstract] [Full Text] [Related]

  • 30. Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.
    Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN, Ruthel G, Blouch RE, Moulton HM, Weller DD, Iversen PL, Bavari S.
    Antimicrob Agents Chemother; 2009 May 27; 53(5):2089-99. PubMed ID: 19223614
    [Abstract] [Full Text] [Related]

  • 31. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
    Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J.
    Nature; 2011 Aug 24; 477(7364):344-8. PubMed ID: 21866101
    [Abstract] [Full Text] [Related]

  • 32. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA, Barnes AB, Wiehle RD, Fontenot GK, Hoenen T, White JM.
    Viruses; 2016 Aug 02; 8(8):. PubMed ID: 27490565
    [Abstract] [Full Text] [Related]

  • 33. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
    Schafer A, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L.
    Curr Med Chem; 2018 Aug 02; 25(38):5177-5190. PubMed ID: 29032747
    [Abstract] [Full Text] [Related]

  • 34. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
    De Burghgraeve T, Kaptein SJ, Ayala-Nunez NV, Mondotte JA, Pastorino B, Printsevskaya SS, de Lamballerie X, Jacobs M, Preobrazhenskaya M, Gamarnik AV, Smit JM, Neyts J.
    PLoS One; 2012 Aug 02; 7(5):e37244. PubMed ID: 22624001
    [Abstract] [Full Text] [Related]

  • 35. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T, Draper K, Brasel T, Freiberg A, Squiquera L, Sidransky D, Sulley J, Taxman DJ.
    Antiviral Res; 2016 Aug 02; 132():210-8. PubMed ID: 27350309
    [Abstract] [Full Text] [Related]

  • 36. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication.
    Reynard O, Nguyen XN, Alazard-Dany N, Barateau V, Cimarelli A, Volchkov VE.
    Viruses; 2015 Dec 01; 7(12):6233-40. PubMed ID: 26633464
    [Abstract] [Full Text] [Related]

  • 37. Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review.
    Sweiti H, Ekwunife O, Jaschinski T, Lhachimi SK.
    Syst Rev; 2015 Nov 25; 4():171. PubMed ID: 26607658
    [Abstract] [Full Text] [Related]

  • 38. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes.
    Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA.
    PLoS Pathog; 2010 Sep 16; 6(9):e1001110. PubMed ID: 20862315
    [Abstract] [Full Text] [Related]

  • 39. A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.
    Flint M, Chatterjee P, Lin DL, McMullan LK, Shrivastava-Ranjan P, Bergeron É, Lo MK, Welch SR, Nichol ST, Tai AW, Spiropoulou CF.
    Nat Commun; 2019 Jan 17; 10(1):285. PubMed ID: 30655525
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
    Covés-Datson EM, Dyall J, DeWald LE, King SR, Dube D, Legendre M, Nelson E, Drews KC, Gross R, Gerhardt DM, Torzewski L, Postnikova E, Liang JY, Ban B, Shetty J, Hensley LE, Jahrling PB, Olinger GG, White JM, Markovitz DM.
    PLoS Negl Trop Dis; 2019 Jul 17; 13(7):e0007595. PubMed ID: 31356611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.